The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.
I had a pet scan last week and an MRI today. The pet scan showed several new lesions and growth of old ones. I was hoping the brain mri was at least stable so I could go into a trial but bad newsthere as well, I have 6 new lesions and some are bleeding. Since the mekinist/dabrafenib iisn’t working its on to next treatment…..temodar. I asked if I could get gamma knife again and they said only if I’m having symptoms. Well of course I’m having symptoms, dizziness and headaches. My oncologist said its not reccommended to have gamma knife more than once. I thought that was WBR? Does anybody know how often you can have gamma knife?
Thanks for your help, I’m running out of options.
I'm sorry. I know this is not the news you were hoping for. I'm sure someone will be along shortly that can answer your question.
Viewing 2 reply threads
You must be logged in to reply to this topic.
About the MRF Patient Forum
The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.
The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.